Who is the Candidate? The Heart Transplant Evaluation Process
References
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052
- Baumwol J. “I Need Help”-A mnemonic to aid timely referral in advanced heart failure. J Heart Lung Transplant. 2017 May;36(5):593-594. doi: 10.1016/j.healun.2017.02.010
- Crespo-Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 Nov;20(11):1505-1535. doi: 10.1002/ejhf.1236
- Kittleson MM, Shah P, Lala A, et al. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry. J Heart Lung Transplant. 2020 Jan;39(1):16-26. doi: 10.1016/j.healun.2019.08.017
- Morris AA, Khazanie P, Drazner MH, et al. Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2021 Oct 12;144(15):e238-e250. doi: 10.1161/CIR.0000000000001016
- Longhi S, Saturi G, Caponetti AG, Gagliardi C, Biagini E. Advanced Heart Failure in a Special Population: Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021 Oct;17(4):685-695. doi: 10.1016/j.hfc.2021.05.012
- Gorter TM, van Veldhuisen DJ, Bauersachs J, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 Jan;20(1):16-37. doi: 10.1002/ejhf.1029
- Greutmann M, Tobler D, Kovacs AH, et al. Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis. 2015 Mar-Apr;10(2):117-27. doi: 10.1111/chd.12201
- Nguyen LS, Coutance G, Ouldamar S, et al. Performance of existing risk scores around heart transplantation: validation study in a 4-year cohort. Transpl Int. 2018 May;31(5):520-530. doi: 10.1111/tri.13122
- Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997 Jun 17;95(12):2660-7. doi: 10.1161/01.cir.95.12.2660
- Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006 Mar 21;113(11):1424-33. doi: 10.1161/CIRCULATIONAHA.105.584102
- Pocock SJ, Ariti CA, McMurray JJ, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013 May;34(19):1404-13. doi: 10.1093/eurheartj/ehs337
- Agostoni P, Corra U, Cattadori G, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10;167(6):2710-8. doi: 10.1016/j.ijcard.2012.06.113
- O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030
- Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008 Jul 29;52(5):347-56. doi: 10.1016/j.jacc.2008.04.028
- Peterson PN, Rumsfeld JS, Liang L, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):25-32. doi: 10.1161/CIRCOUTCOMES.109.854877
- O’Connor CM, Hasselblad V, Mehta RH, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol. 2020 Dec;27(2_suppl):12-18. doi: 10.1177/2047487320962990
- Corra U, Magini A, Paolillo S, Frigerio M. Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction. Eur J Prev Cardiol. 2020 Dec;27(2_suppl):12-18. doi: 10.1177/2047487320962990
- Keteyian SJ, Patel M, Kraus WE, et al. Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. J Am Coll Cardiol. 2016 Feb 23;67(7):780-9. doi: 10.1016/j.jacc.2015.11.050
- Lund LH, Aaronson KD, Mancini DM. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol. 2003 Dec 1;92(11):1350-4. doi: 10.1016/j.amjcard.2003.08.027
- Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH
Jr , Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991 Mar;83(3):778-86. doi: 10.1161/01.cir.83.3.778 - Peterson LR, Schechtman KB, Ewald GA, et al. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant. 2003 Oct;22(10):1141-8. doi: 10.1016/s1053-2498(02)01225-1
- Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000 Dec;36(7):2126-31. doi: 10.1016/s0735-1097(00)00985-2
- Robbins M, Francis G, Pashkow FJ, et al. Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation. 1999 Dec 14;100(24):2411-7. doi: 10.1161/01.cir.100.24.2411
- Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002 Dec 10;106(24):3079-84. doi: 10.1161/01.cir.0000041428.99427.06
- Sarullo FM, Fazio G, Brusca I, et al. Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. Open Cardiovasc Med J. 2010 May 26:4:127-34. doi: 10.2174/1874192401004010127
- Salvioni E, Corra U, Piepoli M, et al. Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction. ESC Heart Fail. 2020 Feb;7(1):371-380. doi: 10.1002/ehf2.12582
- Corra U, Agostoni PG, Anker SD, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 Jan;20(1):3-15. doi: 10.1002/ejhf.979
- Mezzani A. Cardiopulmonary Exercise Testing: Basics of Methodology and Measurements. Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S3-S11. doi: 10.1513/AnnalsATS.201612-997FR
- Canter CE, Shaddy RE, Bernstein D, et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Feb 6;115(5):658-76. doi: 10.1161/CIRCULATIONAHA.106.180449
- Ross HJ, Law Y, Book WM, et al. Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 Feb 23;133(8):802-20. doi: 10.1161/CIR.0000000000000353
- Matkovic M, Milicevic V, Bilbija I, et al. Pulmonary Artery Hypertension as A Risk Factor for Long-Term Survival after Heart Transplantation. Heart Surg Forum. 2021 Jun 11;24(3):E544-E549. doi: 10.1532/hsf.3789
- Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019 Oct;38(10):1056-1066. doi: 10.1016/j.healun.2019.08.004
- Wever-Pinzon O, Edwards LB, Taylor DO, et al. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant. 2017 Apr;36(4):407-417. doi: 10.1016/j.healun.2016.08.008
- Laks H, Marelli D, Fonarow GC, et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003 Jan;125(1):49-59. doi: 10.1067/mtc.2003.62
- Jawitz OK, Raman V, Klapper J, Hartwig M, Patel CB, Milano C. Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. Transpl Int. 2019 Nov;32(11):1194-1202. doi: 10.1111/tri.13481
- Dalal AR. Philosophy of organ donation: Review of ethical facets. World J Transplant. 2015 Jun 24;5(2):44-51. doi: 10.5500/wjt.v5.i2.44
- Hsich E, Singh TP, Cherikh WS, et al. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease. J Heart Lung Transplant. 2022 Oct;41(10):1366-1375. doi: 10.1016/j.healun.2022.07.018
- Chouairi F, Milner A, Sen S, et al. Impact of Obesity on Heart Transplantation Outcomes. J Am Heart Assoc. 2021 Dec 7;10(23):
e021346 . doi: 10.1161/JAHA.121.021346 - Doumouras BS, Fan CS, Mueller B, et al. The effect of pre-heart transplant body mass index on posttransplant outcomes: An analysis of the ISHLT Registry Data. Clin Transplant. 2019 Jul;33(7):
e13621 . doi: 10.1111/ctr.13621 - Liu Y, Padilla FA, Graviss EA, et al. Outcomes of Heart Transplant Recipients with Class II Obesity: A United Network for Organ Sharing Database Analysis. J Surg Res. 2022 Apr:272:69-78. doi: 10.1016/j.jss.2021.11.005
- Foroutan F, Doumouras BS, Ross H, Alba AC. Impact of pretransplant recipient body mass index on post heart transplant mortality: A systematic review and meta-analysis. Clin Transplant. 2018 Aug;32(8):
e13348 . doi: 10.1111/ctr.13348 - Russo MJ, Hong KN, Davies RR, et al. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg. 2010 Jan;251(1):144-52. doi: 10.1097/SLA.0b013e3181b5db3c
- Okoh AK, Selevany M, Heaton J, et al. Outcomes of Obese Patients Bridged to Heart Transplantation with a Left Ventricular Assist Device. ASAIO J. 2021 Feb 1;67(2):137-143. doi: 10.1097/MAT.0000000000001188
- Challapalli J, Maynes EJ, O’Malley TJ, et al. Sleeve Gastrectomy in Patients with Continuous-Flow Left Ventricular Assist Devices: a Systematic Review and Meta-Analysis. Obes Surg. 2020 Nov;30(11):4437-4445. doi: 10.1007/s11695-020-04834-4
- Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446
- Al-Adra DP, Hammel L, Roberts J, et al. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant. 2021;21(2):460-474. 2021 Feb;21(2):460–474. doi: 10.1111/ajt.16318
- Peled Y, Ducharme A, Kittleson M, et al. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant. 2024 Oct;43(10):1529-1628.e54. doi: 10.1016/j.healun.2024.05.010
- Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237
- Bursi F, McNallan SM, Redfield MM, et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol. 2012 Jan 17;59(3):222-31. doi: 10.1016/j.jacc.2011.06.076
- Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J. 2010 Sep;31(18):2280-90. doi: 10.1093/eurheartj/ehq245
- Vakil K, Duval S, Sharma A, et al. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis. Int J Cardiol. 2014 Oct 20;176(3):595-9. doi: 10.1016/j.ijcard.2014.08.072
- Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992 Jan;19(1):48-54. doi: 10.1016/0735-1097(92)90050-w
- Zern EK, Cheng S, Wolfson AM, et al. Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation. Circ Heart Fail. 2020 Feb;13(2):
e006696 . doi: 10.1161/CIRCHEARTFAILURE.119.006696 - Kutty RS, Parameshwar J, Lewis C, et al. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2013 Jun;43(6):1237-42. doi: 10.1093/ejcts/ezs678
- Moayedifar R, Zuckermann A, Aliabadi-Zuckermann A, et al. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg. 2018 Dec 1;54(6):1116-1121. doi: 10.1093/ejcts/ezy214
- Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation. 2006 Nov 21;114(21):2280-7. doi: 10.1161/CIRCULATIONAHA.106.615708
- Rivinius R, Gralla C, Helmschrott M, et al. Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation. Front Cardiovasc Med. 2022 Jun 9:9:
890359 . doi: 10.3389/fcvm.2022.890359 - Jalowiec A, Grady KL, White-Williams C. Heart Transplant Outcomes in Patients With Pretransplant Diabetes Mellitus. Am J Crit Care. 2017 Nov;26(6):482-490. doi: 10.4037/ajcc2017571
- Newman JD, Schlendorf KH, Cox ZL, et al. Post-transplant diabetes mellitus following heart transplantation. J Heart Lung Transplant. 2022 Nov;41(11):1537-1546. doi: 10.1016/j.healun.2022.07.011
- Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med. 2018 Apr 17;168(8):569-576. doi: 10.7326/M17-0939
- OPTN [Internet]. Richmond, VA: Organ Procurement and Transplantation Network; c2025.
Establish Eligibility Criteria and Safety Net for Heart-Kidney and Lung-Kidney Allocation ; 2023 Sep 28 [cited 2025 Mar 8]. Available from:https://optn.transplant.hrsa.gov/policies-bylaws/public-comment/establish-eligibility-criteria-and-safety-net-for-heart-kidney-and-lung-kidney-allocation/ - Danziger-Isakov L, Kumar D; AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019 Sep;33(9):
e13563 . doi: 10.1111/ctr.1356 - CDC [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; c2025.
ACIP Vaccine Recommendations and Guidelines ; 2025 Jan [cited 2025 Mar 8]. Available from:https://www.cdc.gov/acip/vaccine-recommendations/index.html - Peled Y, Ram E, Lavee J, et al. BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response. J Heart Lung Transplant. 2021 Aug;40(8):759-762. doi: 10.1016/j.healun.2021.04.003
- Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489
- Wadei HM, Gonwa TA, Leoni JC, Shah SZ, Aslam N, Speicher LL. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination. Am J Transplant. 2021 Oct;21(10):3496-3499. doi: 10.1111/ajt.16618
- Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008 Feb;14(2):159-72. doi: 10.1002/lt.21278
- Bui QM, Allen LA, LeMond L, Brambatti M, Adler E. Psychosocial Evaluation of Candidates for Heart Transplant and Ventricular Assist Devices: Beyond the Current Consensus. Circ Heart Fail. 2019 Jul;12(7):
e006058 . doi: 10.1161/CIRCHEARTFAILURE.119.006058 - Dew MA, DiMartini AF, Dobbels F, et al. The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. Psychosomatics. 2018 Sep-Oct;59(5):415-440. doi: 10.1016/j.psym.2018.04.003
- Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics. 2006 May-Jun;47(3):213-22. doi: 10.1176/appi.psy.47.3.213
- Duerinckx N, Burkhalter H, Engberg SJ, et al. Correlates and Outcomes of Posttransplant Smoking in Solid Organ Transplant Recipients: A Systematic Literature Review and Meta-Analysis. Transplantation. 2016 Nov;100(11):2252-2263. doi: 10.1097/TP.0000000000001335
- Botha P, Peaston R, White K, Forty J, Dark JH, Parry G. Smoking after cardiac transplantation. Am J Transplant. 2008 Apr;8(4):866-71. doi: 10.1111/j.1600-6143.2007.02119.x
- Kim S. Overview of Cotinine Cutoff Values for Smoking Status Classification. Int J Environ Res Public Health. 2016 Dec 14;13(12):
1236 . doi: 10.3390/ijerph13121236 - Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013 Dec 27;96(12):1015-24. doi: 10.1097/TP.0b013e31829f7579
- Tome S, Said A, Lucey MR. Addictive behavior after solid organ transplantation: what do we know already and what do we need to know? Liver Transpl. 2008 Feb;14(2):127-9. doi: 10.1002/lt.21311
- Thompson GR
3rd , Tuscano JM, Dennis M, et al. A microbiome assessment of medical marijuana. Clin Microbiol Infect. 2017 Apr;23(4):269-270. doi: 10.1016/j.cmi.2016.12.001 - Neyer J, Uberoi A, Hamilton M, Kobashigawa JA. Marijuana and Listing for Heart Transplant: A Survey of Transplant Providers. Circ Heart Fail. 2016 Jul;9(7):
e002851 . doi: 10.1161/CIRCHEARTFAILURE.115.002851 - Maldonado JR, Sher Y, Lolak S, et al. The Stanford Integrated Psychosocial Assessment for Transplantation: A Prospective Study of Medical and Psychosocial Outcomes. Psychosom Med. 2015 Nov-Dec;77(9):1018-30. doi: 10.1097/PSY.0000000000000241
DOI: https://doi.org/10.14797/mdcvj.1512 | Journal eISSN: 1947-6108
Language: English
Page range: 13 - 24
Submitted on: Oct 26, 2024
Accepted on: Feb 7, 2025
Published on: May 15, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2025 Michelle M. Kittleson, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.